Medical Futures Innovation Awards 2011

Anything that makes the quality of a patient’s life bettershould be pursued. Our problem is that we get obsessedwith making money. You have to start somewhere andmake something. If you make something which works,

it’ll make money.

Sir James Black OM(1924-2010)

Nobel LaureateMedical Futures Lifetime Achievement Award Winner

www.medicalfutures.com 6th June 2011 2

organisations and industry to create and mobilise

new routes to funding and work with investors

and industry to facilitate the progression of ideas

to improve patient care.

The best ideas are now being pitched to our

experts. Be one of the first to see the

showcase at Europe’s largest exhibition of

early staged healthcare innovation on the

6th June in Central London, followed by the

Gala Awards ceremony, referred to in the

press as the “Oscars of Healthcare”.

Innovation is the life blood for any organisation

and over the coming years of economic

uncertainty, there has never been a more

pressing demand for healthcare innovation,

especially for technologies or therapies that

seamlessly integrate into front line service

delivery, leading to efficiency gains and enhanced

outcomes for patients. The Medical Futures

Innovation Awards and its peer review process

is one of the world’s leading fora for catalysing

medical innovation. We continuously engage

with the medical funding bodies, venture capital

6th June 2011www.medicalfutures.comwww.medicalfutures.com 6th June 2011 4

A Medical Futures Innovation Award is the UK’smost sought after healthcare accolade, rewarding

ground breaking innovation from frontlineclinicians and scientists. Winning an Award

significantly enhances one’s chance of clinicaland commercial success.


their aspiration to drive forwards their ideas. A series

of workshops called i2 Events, help provide service

transformation; legal; and market oriented commercial

advice to healthcare innovators. So far, thousands

of clinicians, scientists, and entrepreneurs have

attended Medical Futures’ events - connections are

made, and ideas are brought to life.

The best ideas are then assessed by peer review

panels of leading experts. Winning ideas gain critical

endorsement and recognition; access a valuable

support network; and increase their chances of

investment.

Past winners have secured over £80m of

funding, and most importantly many have gone

onto become successful services or products

that are now changing peoples’ lives (see case

studies). Winners are invited to showcase their

innovation at the Medical Futures Innovator’s

Gallery, Europe’s largest showcase of early

staged healthcare innovation. They also receive

their Award at a very high profile ceremony in

the presence of 800 senior and key influencers

in healthcare and business. The event is a

celebration of the synergy of clinical and

commercial success, and is not to be missed.

Each year, thousands of ideas are seen at all

stages of development and many, whilst

academically sound, lack a market facing or

commercial dimension. Indeed many of the more

advanced, venture capital backed businesses we

see, lack medical insight and the clinical evidence

necessary for market penetration.

Anyone involved in the healthcare sector can enter

with ideas at any stage, from concepts through to

trading businesses. Throughout the year, a series

of activities take place in the background that

encourage, support and reward innovators in


One of the unique features of the Medical Futures

process is its world class panel of clinical and

commercial experts, each keen on lending their

support to the innovators of tomorrow. Over 100

clinical experts come together in specialist panels

to judge ideas in numerous medical areas

reflecting key areas of health priority. Short-

listed nominees are invited to pitch to the judges

in a “Dragon’s Den” style, offering a refreshing

and transparent peer review process.


Professor Sir Bruce Keogh KBENHS Medical Director & Surgeon

Baron Lyell of Markyate PC QCFormer Attorney General

Professor Adrian Newland CBEPresident, Royal College Pathologists

Professor Mike Richards CBECancer Lead, Department of Health

Michael SherwoodChief Executive, Goldman Sachs International

Sir Peter SimpsonPast President, Royal College Anaesthetists

Sir Richard SykesFormer Rector of Imperial College London and Chairman, GlaxoSmithKline.

Sir Magdi YacoubProfessor of Cardiothoracic Surgery, Imperial College, London.

Professor Keith FoxPresident, British Cardiovascular Society

Dr Armajit GillPresident, British Dental Association

Professor Ian GilmorePast President, Royal College Physicians

Baroness Susan GreenfieldProfessor of Pharmacology, Oxford

Nicolaus HenkeHead of Global Health Systems, McKinsey & Company

Professor Sheila HollinsPast President, Royal College of Psychiatrists

Professor Dame Janet Husband DBEPast President, Royal College Radiologists

Sir Christopher Kelly KCBChairman of Financial Ombudsman Service

Dr Jane BarrettPresident, Royal College Radiologists

Mrs Brenda BillingtonPresident, Royal College of Ophthalmologists

Sir Victor BlankFormer Chairman, Lloyds TSB

Tony BourneChief Executive, British Medical Association

Dr Archie BrainInventor of the LMA Airway

Professor Sally DaviesDirector R&D, Department of Health

The Rt Hon Lord Darzi of DenhamChairman of the Institute for Global Health Innovation

Professor the Baroness FinlayPast President, Royal Society of Medicine


The peer review committee consisted of the MedicalDirector of the NHS, the head of the British CardiovascularSociety, and other distinguished experts in the field. The

peer review doesn’t get much better than that.

Professor Michael SchneiderHead of the National Heart & Lung Institute,

Medical Futures Innovation Award Winner


Sponsors can build on their relationships withclinicians and policy makers, help realise potential,invest in the future and take a share in the delivery

of life-changing ideas.

Horizon Tracking

There is a growing realisation that companies need to do more than invest in their

own internal R&D to bring forward the important healthcare innovations of tomorrow.

From Penicillin to MRI Scanners and Hip Replacements to the Map of Medicine,

many of the best innovations have come from practitioners, but finding opportunities

is difficult and time consuming. The Innovation Awards will expose you to a wealth

of novel technologies; years before they might otherwise appear on your radar,

many of which will go on to become companies with substantial growth potential.

In addition the NHS is full of pockets of excellence and best practice. This is an

ideal opportunity for your company to find hidden treasures and the up and coming

innovators and leaders of tomorrow.

Broader Visibility

Referred to by the press as the “Oscars of Healthcare”, the Medical Futures Awards

and the Innovation Gallery attracts over 1,000 senior guests in a neutral forum.

They consistently deliver hundreds of positive stories with high visibility across all

forms of media, including television, radio and the broadsheets.

Networking & Reputation Building

Developing and building relationships with policy makers, leading innovators

and opinion formers in healthcare takes time, is expensive and complex.

The Awards offer a unique and neutral environment to build relationships,

encourage cross-fertilization of knowledge across industry and geographical

boundaries, and offer unparalleled opportunities to network.

Corporate Responsibility

Association with the Medical Futures Awards profiles your company's

corporate responsibility agenda of helping improve the health of the nation,

the NHS and the lives of the patients it treats. Innovation is about realising

potential. With over 2m employees in the NHS and private healthcare

sector, the UK has the world’s single largest sources of healthcare intellectual

capital. Your support will help unlock that potential from the future leaders

of healthcare. Sponsoring a process that unlocks talent and creativity -

that moves ideas from concept to market - can only cement your position

at the forefront of innovation.



Past & Present

For other sponsorship opportunitiesplease contact:

E: [email protected]: +44 (0)844 8700056

Single Tickets£250 (maximum of two)

To be seated in best available position

Platinum Table SponsorInvestment £5,000

Host a table of 10 in a prominent position

VIP Champagne Reception

Half page advertisement in the Awards Brochure

10x Tickets to Innovation Showcase (12-4pm)

Gold Table SponsorInvestment £2,500

Host a table of 10 in a good position

VIP Champagne Reception

Company name listed in the Brochure

Prices of packages exclude VAT at 20%.

All proceeds from the Awards Ceremony are Donated to Charity www.medicalfutures.com 6th June 2011 22

“In developing beta blockers and peptic ulcer

drugs, Sir James Black relieved more human

suffering than thousands of doctors have done

in a lifetime at the bedside.”

James Whyte Black was the son of a mining

engineer from Cowdenbeath, a small mining

village in Fife, Scotland. After reading Medicine

at St Andrews he embarked on a career as a

physiologist.

Black thought out of the box, and had a wealth

of ideas of new ways of discovering drugs. In

1964 his ideas yielded a new class of drugs the

“beta-blockers” that have been used to treat high

blood pressure, migranes and heart attacks and

quickly became the world’s best-selling drug.

For most the invention of one blockbuster would

be a lifetime’s work. But Sir James then went

onto discover the anti-ulcer treatment cimetidine

which in the 1970’s also became the biggest

selling prescription drug of any kind in the world.

Sir James was awarded a Nobel Prize for

Medicine in 1988 and was Knighted for services

to medical research in 1981, followed by the

Order of Merit in 2000.

In 2008, in the presence of his wife Professor

Rona MacKie and hundreds of colleagues and

peers, Sir James was recognised with a Medical

Futures Lifetime Achievement Award for changing

people’s lives. Sir James sadly passed away on

22 March 2010, aged 85.

Case Study

Winner of a Medical Futures Lifetime Achievement Award

(1924-2010) Nobel Laureate

www.medicalfutures.com/e/sir-james.html


In the mid 90’s, Dr Helen Lee and colleagues

had a collective vision. Their vision was to

deliver a new generation of simple and

inexpensive, but robust and technically superior

diagnostics for infectious diseases, to the places

within the world that need them most. At the

time they were working in industry but quickly

realised that to achieve their vision they had to

take a huge risk, by leaving secure jobs and

move to the University of Cambridge to establish

an academic unit and subsequently a start-Up

to carry out technology development.

Fast forward a decade and they are well on their

way to achieving their vision. They run a spinout

company, Diagnostics for the Real World (DRW)

based in the Bay Area on the West Coast of the

USA. They employ 30 staff and most importantly

have launched real products that are changing

peoples’ lives. Amazingly, and without

relinquishing control, the founders have raised

$50m from organisations such as NIH, WHO,

CDC and the Technology Transfer Division of

the Wellcome Trust. They have 4 approved

products on the market for diseases such as

Chlamydia and Hepatitis B and their business

model is shrewd with a two tier pricing system

to offer the developing, and middle-low income

countries the benefit of their tests essentially at

cost and sometimes free, subsidised by a

commercial pricing structure in western markets.

They won a Medical Futures Award in 2003,

when their ideas were at an early stage. “Winning

a Medical Futures Award was a tremendous

morale boost for us which also gave us the

validation we needed that what we were doing

was right” said CEO, Dr Lee, whose ten year

plan includes growing the business year on year

whilst continuing to provide equity to the

developing world.

Case Study

Winner of a Medical Futures Innovation Award

Diagnostics for the Real World Ltd


Case Study

Surgeon & Inventor


Brian Thornes, a surgeon from Ireland developed

a novel medical device used in Orthopaedic surgery

to address a common problem in the operative

treatment of broken ankles. He designed a suture

that holds two ends of a bone together replacing

a metal screw which normally had to be removed

in a second operation or, if left in, frequently would

break when the patient started walking again.

The TightRope® has been used on several

celebrity athletes including the likes of Welsh

International, Gavin Hensen, and Chicago Bears

quarterback, Rex Grossman.

“I cannot understate the significance Medical

Futures has had on my career path.” Said Brian

Thornes, “I am grateful to have been one of the

earlier recipients of the Awards. The Judges

recognising the potential for my Tightrope device,

several years before its market success.”

www.ankletightrope.com

The device was licensed to a large medical

device company and the first TightRope® device

was implanted in Ireland in 2004. Over 100,000

units have been sold and used in more than

60,000 patients to date, grossing multiple millions

of revenue and sprouting numerous line

extensions of the technology.


The Positive Mental Attitude (PMA) Football

League is an engaging social venture for sufferers

of mental illness. Created by former professional

footballer and coach, Janette Hynes in 2005,

the PMA aims to help its players achieve better

physical and mental health, thus enabling

recovery and reintegration into the community.

Since winning her Award, Janette’s London

based pilot has been professionalised and a

review of activities demonstrated that of the 350

participants in its first two years, a staggering

75% returned to meaningful education or

employment as a result.

The PMA League has now partnered with the

Football Association, the Football Foundation

and the NHS to ensure secure funding and a

joined-up approach to the use of football as a

tool to help sufferers of mental illness.

As part of her Award, Medical Futures has

mentored Janette and her team and assisted

the restructuring of the PMA from a London

based activity into a scalable national activity

with a growing waiting list of teams eager to join.

A fly on the wall documentary is being filmed

and is soon to be televised. This includes footage

Case Study


Positive Mental Attitude Sports Foundation

of the day Janette received a letter from the

Queen, honouring her with an MBE for services

to disability, as well as a friendly match between

the PMA’s Hackney Football Club and the UK

Parliamentary Football team. The PMA has

widened its remit to include other sports and is

providing skills programmes with employment

opportunities. Over 1,000 individuals with a

mental health diagnosis have benefited from the

PMA sports programme to date, with an

outstanding success rate in helping players

succeed in engaging in further education, training,

voluntary and paid work.

www.pmasports.com


Documents

Medical Futures Innovation Awards 2011